Invesaro

Stocks Comparison

Bunge Global vs CVS HEALTH: revenue, profit, margins and growth compared

Bunge Global brought in $70.3B of revenue in fiscal 2025, CVS HEALTH $402.1B in fiscal 2025. Revenue changed by +32.4% at Bunge Global and +7.8% at CVS HEALTH on the year before, so Bunge Global grew faster. Bunge Global kept 1.2% of its revenue as net profit, CVS HEALTH 0.4%. Free cash flow was -$879M at Bunge Global and $7.8B at CVS HEALTH.

Side by side, latest fiscal year

BGCVS
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$70.3B$402.1B
Revenue growth+32.4%+7.8%
Net income$816M$1.8B
Net margin1.2%0.4%
Free cash flow-$879M$7.8B
Free cash flow margin-1.2%1.9%
Earnings per share (diluted)$4.91$1.39
Cash$1.1B$8.5B
Debt$10.2B$64.6B
Price to earnings22.264.1
Market value$20.9B$114B
Dividend yield2.57%2.98%
Rank by revenue in sector#7 of 93 · Consumer staples#1 of 93 · Consumer staples

Over the years

Revenue
BG FY2021: $59.2BBG FY2023: $67.2BBG FY2023: $59.5BBG FY2024: $53.1BBG FY2025: $70.3BCVS FY2018: $194.6BCVS FY2019: $256.8BCVS FY2020: $268.7BCVS FY2021: $292.1BCVS FY2022: $322.5BCVS FY2023: $357.8BCVS FY2024: $372.8BCVS FY2025: $402.1BFY18FY19FY20FY21FY22FY23FY24FY25
BG $70.3BCVS $402.1B
Net income
BG FY2021: $2.1BBG FY2023: $1.6BBG FY2023: $2.2BBG FY2024: $1.1BBG FY2025: $816MCVS FY2018: -$594MCVS FY2019: $6.6BCVS FY2020: $7.2BCVS FY2021: $8BCVS FY2022: $4.3BCVS FY2023: $8.3BCVS FY2024: $4.6BCVS FY2025: $1.8BFY18FY19FY20FY21FY22FY23FY24FY25
BG $816MCVS $1.8B
Net margin
BG FY2021: 3.5%BG FY2023: 2.4%BG FY2023: 3.8%BG FY2024: 2.1%BG FY2025: 1.2%CVS FY2018: -0.3%CVS FY2019: 2.6%CVS FY2020: 2.7%CVS FY2021: 2.7%CVS FY2022: 1.3%CVS FY2023: 2.3%CVS FY2024: 1.2%CVS FY2025: 0.4%FY18FY19FY20FY21FY22FY23FY24FY25
BG 1.2%CVS 0.4%
Revenue growth
BG FY2023: +13.7%BG FY2023: -11.4%BG FY2024: -10.8%BG FY2025: +32.4%CVS FY2019: +32.0%CVS FY2020: +4.6%CVS FY2021: +8.7%CVS FY2022: +10.4%CVS FY2023: +10.9%CVS FY2024: +4.2%CVS FY2025: +7.8%FY19FY20FY21FY22FY23FY24FY25
BG +32.4%CVS +7.8%
Free cash flow
BG FY2021: -$3.3BBG FY2023: -$6.1BBG FY2023: $2.2BBG FY2024: $524MBG FY2025: -$879MCVS FY2018: $6.8BCVS FY2019: $10.4BCVS FY2020: $13.4BCVS FY2021: $15.7BCVS FY2022: $13.5BCVS FY2023: $10.4BCVS FY2024: $6.3BCVS FY2025: $7.8BFY18FY19FY20FY21FY22FY23FY24FY25
BG -$879MCVS $7.8B

Fiscal years as each company reports them; the two may end in different months.

Questions about Bunge Global and CVS HEALTH

Which is bigger by revenue, Bunge Global or CVS HEALTH?

CVS HEALTH is bigger by revenue: $402.1B in fiscal 2025, against $70.3B for Bunge Global in fiscal 2025.

Which keeps more of its revenue as profit, Bunge Global or CVS HEALTH?

Bunge Global had a net margin of 1.2% in fiscal 2025; CVS HEALTH had 0.4% in fiscal 2025.

Which grew revenue faster, Bunge Global or CVS HEALTH?

In their latest fiscal years revenue changed by +32.4% at Bunge Global and +7.8% at CVS HEALTH.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies